Highlight
- One-year progression of CT emphysema subtypes, specifically combined bronchitic-apical emphysema (CBaE) and diffuse emphysema, independently predicts subsequent accelerated FEV₁ decline in smokers with and without COPD.
- Standard quantitative CT measures of emphysema also correlate with lung function decline but lack independent predictive power when combined with subtype measures.
- Findings support the use of CT emphysema subtype progression as intermediate endpoints to enhance efficiency of clinical trials in COPD.
Specialty calculators
For clinical reference; use professional judgment.

